ER postive
Showing 1 - 25 of 1,361
Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +
Completed
- Breast Cancer
- Breast Neoplasms
- Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
-
Fayetteville, Arkansas
- +1 more
Jan 26, 2023
Endometroid Endometrial Cancer Trial in Baltimore (Alpelisib Pill, Fulvestrant injection)
Not yet recruiting
- Endometroid Endometrial Cancer
- Alpelisib Pill
- Fulvestrant injection
-
Baltimore, MarylandJohns Hopkins Medicine
Dec 7, 2021
Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)
Not yet recruiting
- Carcinoma, Renal Cell
- Autologous alpha-DC1/TBVA vaccine
- Cabozantinib
-
Pittsburgh, PennsylvaniaUPMC Department of Urology
Jan 5, 2023
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma = 2cm
Recruiting
- Lung Adenocarcinoma
- Lobectomy with systemic lymph node dissection
- Segmentectomy with systemic lymph node dissection
-
Yangpu, Shanghai, ChinaShanghai Pulmonary Hospital
Apr 20, 2023
Breast Cancer Trial in Shanghai (ARV-471)
Not yet recruiting
- Breast Cancer
-
Shanghai, ChinaCancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2023
Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- Paclitaxel
- +2 more
- (no location specified)
Sep 12, 2023
Eating Rate Trial in Wageningen (ultra-processed slow eating rate diet, Ultra-processed fast eating rate diet)
Recruiting
- Eating Rate
- ultra-processed slow eating rate diet
- Ultra-processed fast eating rate diet
-
Wageningen, Gelderland, NetherlandsWageningen University
Nov 3, 2023
Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)
Active, not recruiting
- Prurigo Nodularis
- Nalbuphine ER Tablets
- Matching Placebo Tablets
-
Phoenix, Arizona
- +69 more
Jan 31, 2023
Blood and Tumor Samples From Advanced or Metastatic Estrogen
Active, not recruiting
- Advanced Breast Carcinoma
- +8 more
- Biopsy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Chronic Pain, Musculoskeletal Pain, Fibromyalgia Trial in Palo Alto (Empowered Relief for Youth)
Recruiting
- Chronic Pain
- +5 more
- Empowered Relief for Youth
-
Palo Alto, CaliforniaStanford University
Aug 9, 2023
Esophageal Cancer Trial in Guangzhou (Submucosal Saline Injection, Blue laser Imaging and Magnifying Endoscopy)
Recruiting
- Esophageal Cancer
- Submucosal Saline Injection
- Blue laser Imaging and Magnifying Endoscopy
-
Guangzhou, Guangdong, ChinaCancer center, Sun Yat-sen University
Aug 28, 2023
PedSCath Pediatric Sampling Catheter Versus Current Standard of
Recruiting
- Urinary Tract Infections in Children
- PedSCath Pediatric Urinary Catheter
- Standard of Care
-
New York, New YorkNewYork-Presbyterian Queens
May 16, 2022
Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaBiyun Wang, MD
Apr 5, 2023
OCD Trial in Braga (ICBT)
Recruiting
- Obsessive-Compulsive Disorder
- ICBT
-
Braga, Gualtar, PortugalLife and Health Sciences Research Institute, School of Medicine,
Jun 6, 2023
Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)
Recruiting
- Breast Cancer
- Dalpiciclib
- +4 more
-
Shijiazhuang, Hebei, ChinaThe Fourth Hospital of Hebei Medical University
Oct 25, 2023
Breast Cancer Trial in Beijing (18F-FES PET/CT scan)
Recruiting
- Breast Cancer
- 18F-FES PET/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 4, 2022
Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)
Completed
- Nalbuphine
- +2 more
- Nalbuphine ER
- Placebo oral tablet
-
Antrim, Northern Ireland, United Kingdom
- +14 more
Oct 3, 2022
Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)
Active, not recruiting
- Metastatic Breast Cancer
- 17B-estradiol
- +3 more
-
Springfield, Massachusetts
- +2 more
Nov 1, 2022
Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)
Recruiting
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Docetaxel
- +3 more
-
Shanghai, Shanghai, ChinaBreast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
Pain, Chronic Trial (Empowered Relief)
Not yet recruiting
- Pain, Chronic
- Empowered Relief
- (no location specified)
Jun 27, 2023
Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 1, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Advanced Triple-Negative Breast Carcinoma
- +4 more
- Biopsy
- +4 more
-
Birmingham, Alabama
- +9 more
Aug 31, 2022
Emotion Regulation Trial in Oxford (Laboratory tasks in middle childhood/pre-adolescence)
Not yet recruiting
- Emotion Regulation
- Laboratory tasks in middle childhood/pre-adolescence
-
Oxford, OhioMiami University Department of Psychology
Jun 10, 2022